The pace of innovation, both technically and in terms of commercialization strategies, continues to accelerate within the field of molecular diagnostics, making the right strategic partnerships critical to the development of promising new technologies and applications. CHI's Emerging Diagnostic Partnering & Investment Forum will bring together exciting early stage companies with decision makers representing pharma, larger biotechs, and VCs, providing an efficient opportunity to learn about emerging technologies and engage in networking, partnering and investment exploration discussions.
August 19, 2012 | View Agenda | Download Partnering Forum Brochure
LEARN about the latest tools, platforms and applications in molecular diagnostics
HEAR from innovative technology developers working in cancer, infectious disease and other therapeutic areas
DISCUSS strategies to leverage alliances and partnerships to bring diagnostics to market
NETWORK with early stage companies, established diagnostic and platform companies, clinical labs and investors
EXPLORE potential partnership opportunities through one-on-one meetings
MAXIMIZE your experience on site with Partner Direct networking software
Partner Direct is an online networking tool designed to facilitate collaboration amongst emerging companies and potential strategic partners. This partnering software provides the opportunity for forum delegates to connect with company presenters in advance to schedule one-on-one meetings during the event.
Partner Direct will be available to registered attendees of the Emerging Diagnostic Partnering & Investment Forum starting ix weeks before the event, and will remain accessible during and after the forum to allow you to make the most of your time on site.
PROGRAM ADVISORY BOARD:
Brian T. Edmonds, Ph.D., Director, New Technologies, Global External Research & Development, Lilly Corporate Center
Jorge Leon, Ph.D., President, Leomics Consulting
Daniel R. McClernon, McClernon LLC
Charlie Raffin, Consultant
David Rubin, Ph.D., Senior Director, Global Health Innovation Group, Merck & Co.
Ali Tinazli, Director, Business Development & Sales, BioSciences - North America, Sony DADC Austria AG
Katherine Tynan, Ph.D., Business Development & Strategic Consulting for Diagnostics Companies, Tynan Consulting LLC
Penny Wilson, Ph.D., Innovation Platform Leader, Stratified Medicine, Technology Strategy Board